AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AB-Biotics SA (ABB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8208
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprietary supplements, lysozyme and defensin peptides, and infantile colic products. It also provides pyloriosis, radiobal products, vitamin K products, lactobacillus brevis, natural solutions, neuropharmagen testing products, and probiosis products, among others. AB-Biotics offers services such as protocol development, drug development, clinical testing services, financing, research and development, microbiology services, and project execution services, among others. The company markets and supplies its products in Spain and abroad. AB-Biotics is headquartered in Barcelona, Spain.

AB-Biotics SA (ABB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AB-Biotics SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Licensing Agreements 16
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 17
AB-Biotics Enters into Licensing Agreement with Cilag 18
Equity Offering 19
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 19
Asset Transactions 20
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 20
Acquisition 21
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 21
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 22
AB-Biotics SA – Key Competitors 23
AB-Biotics SA – Key Employees 24
AB-Biotics SA – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
AB-Biotics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 17
AB-Biotics Enters into Licensing Agreement with Cilag 18
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 19
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 20
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 21
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 22
AB-Biotics SA, Key Competitors 23
AB-Biotics SA, Key Employees 24

List of Figures
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Amcor Limited
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bangkok Chain Hospital Public Co Ltd (BCH):企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Southern Company Gas:石油・ガス:M&Aディール及び事業提携情報
    Summary Southern Company Gas (SCG), formerly AGL Resources Inc., is an energy services holding company It operates through natural gas distribution, retail operations, wholesale services and midstream. The company serves utility customers through its regulated distribution subsidiaries in the states …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • Keyence Corporation:企業の戦略・SWOT・財務分析
    Keyence Corporation - Strategy, SWOT and Corporate Finance Report Summary Keyence Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Molina Healthcare Inc:企業の戦略・SWOT・財務情報
    Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report Summary Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dalian Port (PDA) Co Ltd (2880):石油・ガス:M&Aディール及び事業提携情報
    Summary Dalian Port (PDA) Co Ltd (Dalian), a subsidiary of Dalian Port Corp Ltd is an oil and gas company that offers port and logistic services. The company offers services such as passenger and roll-on, roll-off terminal, bulk grain terminal, and related logistics services. It also provides oil an …
  • Siemens AG:企業の戦略・SWOT・財務情報
    Siemens AG - Strategy, SWOT and Corporate Finance Report Summary Siemens AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SES SA (SESG):企業の財務・戦略的SWOT分析
    SES SA (SESG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • MedX Health Corp (MDX):企業の財務・戦略的SWOT分析
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Ca Immobilien Anlagen Ag:企業の戦略・SWOT・財務分析
    Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report Summary Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …
  • Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program i …
  • Consolidated Edison Company of New York Inc:企業の戦略的SWOT分析
    Consolidated Edison Company of New York Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Gooderson Leisure Corporation Limited:企業の戦略・SWOT・財務情報
    Gooderson Leisure Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Gooderson Leisure Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Interim HealthCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Interim HealthCare Inc (IHC), formerly Medical Personnel Pool Inc, is a healthcare service provider that offers home care and home health care services. The center provides senior care, pediatric nursing and physical, occupational and speech therapy. Its specialized homecare services include …
  • Taylor Communications Inc:企業の戦略的SWOT分析
    Taylor Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆